Rap2A is upregulated in invasive cells dissected from follicular thyroid cancer

Journal of Thyroid Research

Volumn 2011, Issue , 2011, Pages

  Prabakaran, Indira ^a   Grau, Jillian R ^a   Lewis, Robert ^a   Fraker, Douglas L ^a   Guvakova, Marina A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE PROTEINASE; SOMATOMEDIN C RECEPTOR; THYROTROPIN RECEPTOR;

ADENOMA; ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CARCINOMA CELL; CCND2 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IGF 1R GENE; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; PCSK2 GENE; PLAB GENE; PRIORITY JOURNAL; RAP2A GENE; THYROID CARCINOMA; THYROID PARAFOLLICULAR CELL; TSHR GENE; TUMOR INVASION;

EID: 84864415924     PISSN: 20908067     EISSN: 20420072     Source Type: Journal    
DOI: 10.4061/2011/979840     Document Type: Article

References (29)

1. L. Enewold, K. Zhu, E. Ron et al., "Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005", Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 3, pp. 784-791, 2009.
2. C. Y. Lo, W. F. Chan, K. Y. Lam, and K. Y. Wan, "Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival", Annals of Surgery, vol. 242, no. 5, pp. 708-715, 2005.
3. Z. W. Baloch and V. A. Li Volsi, "Our approach to follicularpatterned lesions of the thyroid", Journal of Clinical Pathology, vol. 60, no. 3, pp. 244-250, 2007. (Pubitemid 46447737)
4. R. L. Witt, "Initial surgical management of thyroid cancer", Surgical Oncology Clinics of North America, vol. 17, no. 1, pp. 71-91, 2008.
5. J. L. Hunt, V. A. Livolsi, Z. W. Baloch et al., "A novel microdissection and genotyping of follicular-derived thyroid tumors to predict aggressiveness", Human Pathology, vol. 34, no. 4, pp. 375-380, 2003. (Pubitemid 36535022)
6. M. Eszlinger, K. Krohn, S. Hauptmann, H. Dralle, T. J. Giordano, and R. Paschke, "Perspectives for improved and more accurate classification of thyroid epithelial tumors", Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 9, pp. 3286-3294, 2008.
7. F. Weber, R. E. Teresi, C. E. Broelsch, A. Frilling, and C. Eng, "A limited set of humanMicroRNA Is deregulated in follicular thyroid carcinoma", Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 9, pp. 3584-3591, 2006. (Pubitemid 44402141)
8. J. Becker, P. Schmidt, F. Musshoff, M. Fitzenreiter, and B. Madea, "MOR1 receptor mRNA expression in human brains of drug-related fatalities-a real-time PCR quantification", Forensic Science International, vol. 140, no. 1, pp. 13-20, 2004. (Pubitemid 38169563)
9. K. Kaserer, V. Knezevic, B. Pichlhöfer et al., "Construction of cDNA libraries from microdissected benign and malignant thyroid tissue", Laboratory Investigation, vol. 82, no. 12, pp. 1707-1714, 2002. (Pubitemid 35462983)
10. R. N. Van Gelder, M. E. Von Zastrow, A. Yool, W. C. Dement, J. D. Barchas, and J. H. Eberwine, "Amplified RNA synthesized from limited quantities of heterogeneous cDNA", Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 5, pp. 1663-1667, 1990.
11. H. Zhao, T. Hastie, M. L. Whitfield, A. L. Børresen-Dale, and S. S. Jeffrey, "Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis", BMC Genomics, vol. 3, article 31, 2002.
12. A. Ciampolillo, C. De Tullio, E. Perlino, and E. Maiorano, "The IGF-I axis in thyroid carcinoma", Current Pharmaceutical Design, vol. 13, no. 7, pp. 729-735, 2007. (Pubitemid 46510748)
13. C. García-Jiménez and P. Santisteban, "TSH signalling and cancer", Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 51, no. 5, pp. 654-671, 2007.
14. S. Chevillard, N. Ugolin, P. Vielh et al., "Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications", Clinical Cancer Research, vol. 10, no. 19, pp. 6586-6597, 2004. (Pubitemid 39346555)
15. F. Weber, L. Shen, M. A. Aldred et al., "Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination", Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 5, pp. 2512-2521, 2005. (Pubitemid 40686285)
16. D. Shibru, J. Hwang, E. Khanafshar, Q. Y. Duh, O. H. Clark, and E. Kebebew, "Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?" Cancer, vol. 113, no. 5, pp. 930-935, 2008.
17. F. Weber, M. A. Aldred, C. D. Morrison et al., "Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis", Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 2, pp. 1149-1155, 2005. (Pubitemid 40279247)
18. S. Glöckner, H. Buurman, W. Kleeberger, U. Lehmann, and H. Kreipe, "Marked intratumoral heterogeneity of c-myc and cyclinD1 but not of c-erbB2 amplification in breast cancer", Laboratory Investigation, vol. 82, no. 10, pp. 1419-1426, 2002. (Pubitemid 35191545)
19. S. M. Wiseman, T. R. Loree, W. L. Hicks et al., "Anaplastic thyroid cancer evolved from papillary carcinoma: demonstration of anaplastic transformation by means of the intersimple sequence repeat polymerase chain reaction", Archives of Otolaryngology-Head and Neck Surgery, vol. 129, no. 1, pp. 96-100, 2003. (Pubitemid 36070883)
20. S. J. McLeod, A. H. Y. Li, R. L. Lee, A. E. Burgess, and M. R. Gold, "The Rap GTPases regulate B cell migration toward the chemokine stromal cell-derived factor-1 (CXCL12): potential role for Rap2 in promoting B cell migration", Journal of Immunology, vol. 169, no. 3, pp. 1365-1371, 2002. (Pubitemid 34809180)
21. K. Taira, M. Umikawa, K. Takei et al., "The traf2-and nckinteracting kinase as a putative effector of Rap2 to regulate actin cytoskeleton", The Journal of Biological Chemistry, vol. 279, no. 47, pp. 49488-49496, 2004. (Pubitemid 39625836)
22. T. Hirata, H. Nagai, K. Koizumi et al., "Amplification, upregulation and over-expression of C3G (CRK SH3 domainbinding guanine nucleotide-releasing factor) in non-small cell lung cancers", Journal of Human Genetics, vol. 49, no. 6, pp. 290-295, 2004. (Pubitemid 38899703)
23. V. Yajnik, C. Paulding, R. Sordella et al., "DOCK4, a GTPase activator, is disrupted during tumorigenesis", Cell, vol. 112, no. 5, pp. 673-684, 2003. (Pubitemid 36331779)
24. D. H. Gutmann, S. Saporito-Irwin, J. E. DeClue, R. Wienecke, and A. Guha, "Alterations in the rap1 signaling pathway are common in human gliomas", Oncogene, vol. 15, no. 13, pp. 1611-1616, 1997. (Pubitemid 27464655)
25. L. Zhang, L. Chenwei, R. Mahmood et al., "Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer", Cancer Research, vol. 66, no. 2, pp. 898-906, 2006. (Pubitemid 43165956)
26. A. Nellore, K. Paziana, C. Ma et al., "Loss of rap1GAP in papillary thyroid cancer", Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 3, pp. 1026-1032, 2009.
27. X. Dong, C. Korch, and J. L. Meinkoth, "Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells", Endocrine-Related Cancer, vol. 18, no. 3, pp. 301-310, 2011.
28. C. L. Bailey, P. Kelly, and P. J. Casey, "Activation of Rap1 promotes prostate cancermetastasis", Cancer Research, vol. 69, no. 12, pp. 4962-4968, 2009.
29. M. Itoh, C. M. Nelson, C. A. Myers, and M. J. Bissell, "Rap1 integrates tissue polarity, lumen formation, and tumorigenic potential in human breast epithelial cells", Cancer Research, vol. 67, no. 10, pp. 4759-4766, 2007. (Pubitemid 46910183)